Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$31.15 - $33.39 $1.73 Million - $1.85 Million
-55,500 Reduced 36.63%
96,000 $3.19 Million
Q3 2022

Nov 10, 2022

SELL
$30.9 - $33.55 $330,630 - $358,984
-10,700 Reduced 6.6%
151,500 $4.78 Million
Q2 2022

Aug 12, 2022

BUY
$23.75 - $31.69 $2.91 Million - $3.88 Million
122,500 Added 308.56%
162,200 $4.93 Million
Q1 2022

May 13, 2022

BUY
$19.97 - $26.94 $792,809 - $1.07 Million
39,700 New
39,700 $1.03 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.